US FDA GRANTS PV-10 ORPHAN DRUG DESIGNATION FOR NEUROBLASTOMA
November 05, 2018 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company was granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA)...
First-Time Team RMHC Marathon Runner Dedicates 2011 Chicago Marathon to Eight-Year-Old Son Battling Cancer
October 06, 2011 11:00 ET
|
Ronald McDonald House Charities Global
OAK BROOK, IL--(Marketwire - Oct 6, 2011) - Running a marathon is a challenge; both physically and mentally, but to Mark Johnston, it's nothing compared to the race his son Luke has been running...